Delaware’s Injury & Medical Malpractice Leaders

  1. Home
  2.  | 
  3. Dangerous and Defective Products
  4.  | Ranitidine (Zantac)

Ranitidine (Zantac)

The Food and Drug Administration (“FDA”) issued an order on April 1, 2020 requesting that all manufacturers of prescription and over-the-counter ranitidine drugs (commonly sold as Zantac) immediately recall their products.

The FDA has been investigating impurities in these medications for some time and is specifically concerned about Nitrosodimethylamine (“NDMA”). NDMA is a probable B2 human carcinogen that is found in small amounts in food and water. However, the FDA’s testing showed that the level of NDMA in ranitidine products appeared to increase significantly as the product experienced temperature differences during distribution and while sitting on the store shelf. Consumers taking these products could ingest a higher than recommended daily amount of NDMA.

According to the World Health Organization, high amounts of NDMA have been linked to gastric or colorectal cancers. It is also extremely toxic to the liver.

Patients who have been taking ranitidine and are concerned about the health risks should check with their doctor prior to stopping the medication. If you or a loved one has suffered a serious health issue or cancer due to the continued use of prescription or over-the-counter ranitidine, please contact our office today for a FREE consultation at 888-395-7576.